ADRB2 and chronic obstructive pulmonary disease: β2AR agonists are reported to show peripheral side effects such as tachycardia, palpitation, pulmonary edema, myocardial ischemia, and cardiac arrhythmia due to activation of βAR in the peripheral tissues.